Elimination of HIV-1-infected cells by broadly neutralizing antibodies

被引:0
|
作者
Timothée Bruel
Florence Guivel-Benhassine
Sonia Amraoui
Marine Malbec
Léa Richard
Katia Bourdic
Daniel Aaron Donahue
Valérie Lorin
Nicoletta Casartelli
Nicolas Noël
Olivier Lambotte
Hugo Mouquet
Olivier Schwartz
机构
[1] Virus and Immunity Unit,Department of Virology
[2] Institut Pasteur,Department of Immunology
[3] CNRS-URA 3015,Division of Immuno
[4] Laboratory of Humoral Response to Pathogens,Virology
[5] Institut Pasteur,undefined
[6] CNRS-URA 1961,undefined
[7] Université Paris Sud,undefined
[8] UMR-1184,undefined
[9] CEA,undefined
[10] DSV/iMETI,undefined
[11] IDMIT,undefined
[12] Inserm,undefined
[13] U1184,undefined
[14] Center for Immunology of Viral Infections and Autoimmune Diseases,undefined
[15] APHP,undefined
[16] Service de Médecine Interne–Immunologie Clinique,undefined
[17] Hôpitaux Universitaires Paris Sud,undefined
[18] Vaccine Research Institute,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Fc region of HIV-1 Env-specific broadly neutralizing antibodies (bNAbs) is required for suppressing viraemia, through mechanisms which remain poorly understood. Here, we identify bNAbs that exert antibody-dependent cellular cytotoxicity (ADCC) in cell culture and kill HIV-1-infected lymphocytes through natural killer (NK) engagement. These antibodies target the CD4-binding site, the glycans/V3 and V1/V2 loops on gp120, or the gp41 moiety. The landscape of Env epitope exposure at the surface and the sensitivity of infected cells to ADCC vary considerably between viral strains. Efficient ADCC requires sustained cell surface binding of bNAbs to Env, and combining bNAbs allows a potent killing activity. Furthermore, reactivated infected cells from HIV-positive individuals expose heterogeneous Env epitope patterns, with levels that are often but not always sufficient to trigger killing by bNAbs. Our study delineates the parameters controlling ADCC activity of bNAbs, and supports the use of the most potent antibodies to clear the viral reservoir.
引用
收藏
相关论文
共 50 条
  • [21] Coevolution of HIV-1 and broadly neutralizing antibodies
    Doria-Rose, Nicole A.
    Landais, Elise
    CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) : 286 - 293
  • [22] Broadly Neutralizing Antibodies for HIV-1 Prevention
    Walsh, Stephen R.
    Seaman, Michael S.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
    Caskey, Marina
    Klein, Florian
    Lorenzi, Julio C. C.
    Seaman, Michael S.
    West, Anthony P., Jr.
    Buckley, Noreen
    Kremer, Gisela
    Nogueira, Lilian
    Braunschweig, Malte
    Scheid, Johannes F.
    Horwitz, Joshua A.
    Shimeliovich, Irina
    Ben-Avraham, Sivan
    Witmer-Pack, Maggi
    Platten, Martin
    Lehmann, Clara
    Burke, Leah A.
    Hawthorne, Thomas
    Gorelick, Robert J.
    Walker, Bruce D.
    Keler, Tibor
    Gulick, Roy M.
    Faetkenheuer, Gerd
    Schlesinger, Sarah J.
    Nussenzweig, Michel C.
    NATURE, 2015, 522 (7557) : 487 - +
  • [24] Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
    Marina Caskey
    Florian Klein
    Julio C. C. Lorenzi
    Michael S. Seaman
    Anthony P. West
    Noreen Buckley
    Gisela Kremer
    Lilian Nogueira
    Malte Braunschweig
    Johannes F. Scheid
    Joshua A. Horwitz
    Irina Shimeliovich
    Sivan Ben-Avraham
    Maggi Witmer-Pack
    Martin Platten
    Clara Lehmann
    Leah A. Burke
    Thomas Hawthorne
    Robert J. Gorelick
    Bruce D. Walker
    Tibor Keler
    Roy M. Gulick
    Gerd Fätkenheuer
    Sarah J. Schlesinger
    Michel C. Nussenzweig
    Nature, 2015, 522 : 487 - 491
  • [25] Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein
    Bardhi, Ariola
    Wu, Yanling
    Chen, Weizao
    Li, Wei
    Zhu, Zhongyu
    Zheng, Jian Hua
    Wong, Hing
    Jeng, Emily
    Jones, Jennifer
    Ochsenbauer, Christina
    Kappes, John C.
    Dimitrov, Dimiter S.
    Ying, Tianlei
    Goldstein, Harris
    JOURNAL OF VIROLOGY, 2017, 91 (20)
  • [26] Broadly Neutralizing Antibodies for HIV Eradication
    Kathryn E. Stephenson
    Dan H. Barouch
    Current HIV/AIDS Reports, 2016, 13 : 31 - 37
  • [27] Broadly Neutralizing Antibodies for HIV Eradication
    Stephenson, Kathryn E.
    Barouch, Dan H.
    CURRENT HIV/AIDS REPORTS, 2016, 13 (01) : 31 - 37
  • [28] Broadly Neutralizing Antibodies for HIV Prevention
    Karuna, Shelly T.
    Corey, Lawrence
    ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 : 329 - 346
  • [29] Frequencies of Broadly Neutralizing Antibodies in HIV-1 Clades A and D of Chronically Infected Ugandans
    Kintu, Christopher
    Bagaya, Bernard S.
    Lutwama, Fredrick
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 113 - 113
  • [30] Alemtuzumab-induced elimination of HIV-1-infected immune cells
    Ruxrungtham, Kiat
    Sirivichayakul, Sunee
    Buranapraditkun, Supranee
    Krause, Werner
    JOURNAL OF VIRUS ERADICATION, 2016, 2 (01) : 12 - 18